Correlation Between UnitedHealth Group and Partners Value

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both UnitedHealth Group and Partners Value at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UnitedHealth Group and Partners Value into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between UnitedHealth Group CDR and Partners Value Investments, you can compare the effects of market volatilities on UnitedHealth Group and Partners Value and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UnitedHealth Group with a short position of Partners Value. Check out your portfolio center. Please also check ongoing floating volatility patterns of UnitedHealth Group and Partners Value.

Diversification Opportunities for UnitedHealth Group and Partners Value

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between UnitedHealth and Partners is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding UnitedHealth Group CDR and Partners Value Investments in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Partners Value Inves and UnitedHealth Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UnitedHealth Group CDR are associated (or correlated) with Partners Value. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Partners Value Inves has no effect on the direction of UnitedHealth Group i.e., UnitedHealth Group and Partners Value go up and down completely randomly.

Pair Corralation between UnitedHealth Group and Partners Value

Assuming the 90 days trading horizon UnitedHealth Group CDR is expected to under-perform the Partners Value. But the stock apears to be less risky and, when comparing its historical volatility, UnitedHealth Group CDR is 1.39 times less risky than Partners Value. The stock trades about -0.11 of its potential returns per unit of risk. The Partners Value Investments is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest  10,100  in Partners Value Investments on September 21, 2024 and sell it today you would earn a total of  6,399  from holding Partners Value Investments or generate 63.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

UnitedHealth Group CDR  vs.  Partners Value Investments

 Performance 
       Timeline  
UnitedHealth Group CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days UnitedHealth Group CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Partners Value Inves 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Partners Value Investments are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Partners Value sustained solid returns over the last few months and may actually be approaching a breakup point.

UnitedHealth Group and Partners Value Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with UnitedHealth Group and Partners Value

The main advantage of trading using opposite UnitedHealth Group and Partners Value positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UnitedHealth Group position performs unexpectedly, Partners Value can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Partners Value will offset losses from the drop in Partners Value's long position.
The idea behind UnitedHealth Group CDR and Partners Value Investments pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance